ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,631Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 337

$506K Total Retail Price of All Prescriptions

Rank: 74 out of 337

367 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 367 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 367 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 10,125 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 495 459 1 1
LISINOPRIL 381 374 2 2
AMLODIPINE BESYLATE 378 368 3 3
FUROSEMIDE 334 318 4 8
OMEPRAZOLE 287 287 5 4
METOPROLOL TARTRATE 282 269 6 6
METFORMIN HCL 281 273 7 12
TRAZODONE HCL 274 258 8 16
WARFARIN SODIUM 256 256 9 11
METOPROLOL SUCCINATE 250 245 10 21
ATORVASTATIN CALCIUM 242 207 11 7
LEVOTHYROXINE SODIUM 234 223 12 5
GABAPENTIN 194 174 13 20
SERTRALINE HCL 158 137 14 18
ATENOLOL 157 146 15 10
ZOLPIDEM TARTRATE 148 135 16 23
ALLOPURINOL 148 135 16 28
LOSARTAN POTASSIUM 112 93 18 15
POTASSIUM CHLORIDE 111 111 19 62
SYNTHROID 106 105 20 41
ROPINIROLE HCL 100 100 21 141
CITALOPRAM HBR 99 81 22 17
KLOR-CON 10 97 97 23 158
MIRTAZAPINE 92 92 24 27
NAMENDA 89 89 25 35
DIGOXIN 88 88 26 58
LIDODERM 83 83 27 82
CRESTOR 83 83 27 29
LIPITOR 82 76 29 33
KLOR-CON M20 78 74 30 65
ENALAPRIL MALEATE 78 78 30 37
DIOVAN 75 75 32 26
HYDROCODONE-ACETAMINOPHEN 74 74 S3 33 13
LANTUS 71 71 34 49
TAMSULOSIN HCL 71 71 34 25
GLIPIZIDE 70 70 36 45
DONEPEZIL HCL 69 69 37 22
GLYBURIDE 69 57 R 37 53
ESCITALOPRAM OXALATE 69 63 37 66
PREDNISONE 68 68 40 40
HYDROCHLOROTHIAZIDE 68 67 40 9
FLUOXETINE HCL 67 61 42 57
OXYCODONE HCL 66 66 S2 43 63
COLCRYS 64 64 44 128
ALENDRONATE SODIUM 63 63 45 19
OXYBUTYNIN CHLORIDE ER 62 62 46 124
CLOPIDOGREL 60 60 47 42
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 48 60
QUINAPRIL HCL 59 59 48 50
AZITHROMYCIN 54 52 50 51
MELOXICAM 52 51 51 54
PRAVASTATIN SODIUM 52 52 51 14
DILTIAZEM 24HR CD 51 51 53 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.